Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012-07-12 00:18 | 2012-07-09 | HAE | HAEMONETICS CORP | ALLEN PETER M | Officer | OPT+S | $73.98 | 10,000 | $739,800 | 11,910 |
| 2012-07-11 23:09 | 2012-07-10 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $53.13 | 18,000 | $956,356 | 13,651,682 |
| 2012-07-12 00:21 | 2012-07-09 | HAE | HAEMONETICS CORP | HANLON SUSAN M | Officer | OPT+S | $73.98 | 7,282 | $538,751 | 7,445 |
| 2012-07-12 01:42 | 2012-07-09 | ARAY | Accuray Incorporated | Thomson Euan | Officer | OPT+S | $6.28 | 20,000 | $125,664 | 291,029 |
| 2012-07-11 23:24 | 2012-07-09 | OSUR | ORASURE TECHNOLOGIES INC | Michels Douglas A | Director, Officer | OPT+S | $13.64 | 62,100 | $847,044 | 578,782 |
| 2012-07-11 23:23 | 2012-07-09 | OSUR | ORASURE TECHNOLOGIES INC | Lee Stephen R | Officer | OPT+S | $14.00 | 53,811 | $753,354 | 45,923 |
| 2012-07-11 18:23 | 2012-07-10 | ICUI | ICU MEDICAL INC/DE | LOPEZ GEORGE A | Director, Officer, 10% owner | SELL | $52.98 | 4,300 | $227,828 | 333,919 |
| 2012-07-09 20:28 | 2012-07-05 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $53.68 | 27,000 | $1,449,290 | 13,669,682 |
| 2012-07-10 01:27 | 2012-07-09 | ICUI | ICU MEDICAL INC/DE | LOPEZ GEORGE A | Director, Officer, 10% owner | SELL | $52.95 | 20,700 | $1,095,995 | 333,919 |
| 2012-07-06 23:39 | 2012-07-03 | MRIC | ClearPoint Neuro, Inc. | Malernee James K. Jr. | Director | BUY | $0.00 | 45,454 | $0 | 182,326 |
| 2012-07-06 23:26 | 2012-07-03 | MRIC | ClearPoint Neuro, Inc. | Conway Bruce C. | Director | BUY | $0.00 | 100,000 | $0 | 1,913,568 |
| 2012-07-07 00:03 | 2012-07-03 | MRIC | ClearPoint Neuro, Inc. | SPENCER JOHN N JR | Director | BUY | $0.00 | 9,981 | $0 | 27,787 |
| 2012-07-06 23:49 | 2012-07-03 | MRIC | ClearPoint Neuro, Inc. | PIETRANGELO MICHAEL | Director | BUY | $0.00 | 90,000 | $0 | 163,263 |
| 2012-07-07 02:44 | 2012-07-06 | OSUR | ORASURE TECHNOLOGIES INC | Michels Douglas A | Director, Officer | OPT+S | $13.14 | 60,000 | $788,160 | 578,782 |
| 2012-07-07 02:43 | 2012-07-05 | OSUR | ORASURE TECHNOLOGIES INC | Lee Stephen R | Officer | OPT+S | $12.85 | 62,021 | $796,970 | 45,923 |
| 2012-07-07 02:42 | 2012-07-05 | OSUR | ORASURE TECHNOLOGIES INC | KUNA MARK L | Officer | OPT+S | $12.91 | 60,920 | $786,294 | 35,072 |
| 2012-07-05 20:42 | 2012-07-02 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | Director, Officer | OPT+S | $74.01 | 4,500 | $333,063 | 48,171 |
| 2012-07-05 17:12 | 2012-07-02 | LMAT | LEMAITRE VASCULAR INC | LeMaitre Cornelia W | Director, Officer | SELL | $6.00 | 565 | $3,390 | 272,844 |
| 2012-07-05 23:32 | 2012-07-02 | PODD | INSULET CORP | DePietro Ruthann | Officer | OPT+S | $21.08 | 6,000 | $126,493 | 18,351 |
| 2012-07-06 02:08 | 2012-07-02 | OSUR | ORASURE TECHNOLOGIES INC | SPAIR RONALD H | Director, Officer | OPT+S | $11.50 | 207,800 | $2,390,199 | 187,767 |
| 2012-07-06 02:06 | 2012-07-03 | OSUR | ORASURE TECHNOLOGIES INC | Michels Douglas A | Director, Officer | OPT+S | $12.71 | 210,021 | $2,668,632 | 578,782 |
| 2012-07-05 23:42 | 2012-07-03 | DXCM | DEXCOM INC | GREGG TERRANCE H | Director, Officer | SELL | $13.03 | 5,000 | $65,154 | 969,889 |
| 2012-07-06 00:00 | 2012-07-03 | JANI | RenovaCare Inc. | Kalen Capital Corp | 10% owner | BUY | $0.01 | 3,500,000 | $35,000 | 29,264,800 |
| 2012-07-03 23:00 | 2012-07-02 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $54.58 | 18,000 | $982,453 | 13,696,682 |
| 2012-07-03 23:49 | 2012-06-29 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | Officer | OPT+S | $74.00 | 5,000 | $370,000 | 8,497 |
| 2012-07-03 23:41 | 2012-07-02 | PODD | INSULET CORP | DeSisto Duane | Director, Officer | OPT+S | $21.36 | 20,000 | $427,170 | 141,077 |
| 2012-07-03 23:37 | 2012-07-02 | PODD | INSULET CORP | ROBERTS BRIAN K | Officer | OPT+S | $21.27 | 10,000 | $212,728 | 77,995 |
| 2012-07-03 20:30 | 2012-07-03 | CMXI | Nuo Therapeutics, Inc. | Maslan Andrew Scott | Officer | BUY | $1.08 | 5,000 | $5,400 | 102,780 |
| 2012-07-03 20:29 | 2012-07-03 | CMXI | Nuo Therapeutics, Inc. | ROSENDALE MARTIN P | Director, Officer | BUY | $1.15 | 8,000 | $9,200 | 158,251 |
| 2012-07-03 19:59 | 2012-06-29 | MDXG-OB | MIMEDX GROUP, INC. | GORLIN STEVE | Director | SELL | $1.55 | 1,000,000 | $1,550,000 | 601,857 |
| 2012-07-03 21:29 | 2012-07-03 | JANI | RenovaCare Inc. | JENKINS DAVID E | Director | BUY | $0.01 | 3,500,000 | $35,000 | 3,500,000 |
| 2012-07-04 00:18 | 2012-07-03 | JANI | RenovaCare Inc. | JENKINS DAVID E | Director | SELL | $0.01 | 3,500,000 | $35,000 | 0 |
| 2012-06-29 22:13 | 2012-06-27 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $54.03 | 27,000 | $1,458,745 | 13,714,682 |
| 2012-06-30 01:49 | 2012-06-29 | LMAT | LEMAITRE VASCULAR INC | LeMaitre Cornelia W | Director, Officer | SELL | $6.00 | 1,718 | $10,308 | 273,409 |
| 2012-06-26 20:41 | 2012-06-25 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $53.78 | 18,000 | $968,000 | 13,741,682 |
| 2012-06-26 00:18 | 2012-06-21 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | Officer | OPT+S | $71.14 | 12,000 | $853,656 | 8,497 |
| 2012-06-26 01:07 | 2012-06-25 | ICUI | ICU MEDICAL INC/DE | LOPEZ GEORGE A | Director, Officer, 10% owner | SELL | $53.42 | 25,000 | $1,335,413 | 333,919 |
| 2012-06-22 21:29 | 2012-06-22 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $53.93 | 9,000 | $485,342 | 13,759,682 |
| 2012-06-21 21:42 | 2012-06-20 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $54.61 | 18,000 | $982,926 | 13,768,682 |
| 2012-06-22 00:05 | 2012-06-20 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | Officer | OPT+S | $72.31 | 24,000 | $1,735,404 | 8,497 |
| 2012-06-22 00:05 | 2012-06-19 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | Officer | OPT+S | $72.35 | 14,000 | $1,012,939 | 8,497 |
| 2012-06-19 21:34 | 2012-06-15 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $54.32 | 27,000 | $1,466,713 | 13,786,682 |
| 2012-06-18 23:05 | 2012-06-15 | DCTH | DELCATH SYSTEMS, INC. | LEUNG GABRIEL | Director | BUY | $1.57 | 7,500 | $11,762 | 15,847 |
| 2012-06-15 23:32 | 2012-06-14 | MRIC | ClearPoint Neuro, Inc. | Conway Bruce C. | Director | BUY | $0.95 | 3,000 | $2,860 | 1,000 |
| 2012-06-15 23:43 | 2012-06-14 | MRIC | ClearPoint Neuro, Inc. | PIETRANGELO MICHAEL | Director | BUY | $0.95 | 5,000 | $4,750 | 73,263 |
| 2012-06-15 00:29 | 2012-06-13 | MRIC | ClearPoint Neuro, Inc. | Conway Bruce C. | Director | BUY | $1.10 | 10,000 | $10,950 | 10,000 |
| 2012-06-14 23:20 | 2012-06-13 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $52.01 | 18,000 | $936,218 | 13,813,682 |
| 2012-06-14 20:02 | 2012-06-12 | UFPT | UFP TECHNOLOGIES INC | GESTAL KENNETH L | Director | SELL | $16.40 | 5,000 | $82,000 | 0 |
| 2012-06-13 18:56 | 2012-06-12 | MRIC | ClearPoint Neuro, Inc. | Conway Bruce C. | Director | BUY | $1.20 | 2,250 | $2,700 | 1,500 |
| 2012-06-13 23:48 | 2012-06-11 | PODD | INSULET CORP | DePietro Ruthann | Officer | OPT+S | $19.96 | 9,287 | $185,333 | 18,315 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.